A Caricature?

Patrick H. Cleveland (The Scientist, Nov. 23, 1992, page 12) laments growing antipathy toward animal experimentation, but he gives the animal protection movement too much credit. The movement is highly fractionated, wastes much of its resources on mass mailings, and commits only a small fraction of its resources to animal research campaigns. In fact, much opposition to animal research is scientific. I doubt I shock many readers of The Scientist when I suggest that many, if not most, animal exp

Written byStephen Kaufman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In fact, much opposition to animal research is scientific. I doubt I shock many readers of The Scientist when I suggest that many, if not most, animal experimentation projects are poorly conceived. Because animal experiments cannot disprove hypotheses about human anatomy, physiology, or pathology, they do not constitute human medical research in the strictest Popperian sense. Most nonscientists are unfamiliar with Karl Popper, a 20th-century philosopher of science, but many can recognize that "animal models" are often poor analogs to human conditions.

Cleveland denounces animal rights, but he does not offer a cohesive alternative ethic. Do we have the right to submit innocent, sentient creatures to pain and/or suffering for supposed human benefit? Many people are concluding that animal research rests on an ethic of "the ends justify the means," which they find unacceptable. I suggest that the notion of a wealthy and violent animal rights movement is a caricature ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies